Special Interest Group (SIG) Sessions (max 21.75 AMA PRA Category 1 Credits)

The featured sessions available for CME are as follows:

Autoimmune Neurology

  • Beyond the IgG4 antibody subclass in MuSK myasthenia gravis: novel evidence for the pathogenicity of IgG1,2 and 3
  • CaVα2δ Autoimmune Encephalitis: A Novel Antibody and Its Characteristics
  • Cerebrospinal Fluid Oligoclonal Bands in Anti-NMDA Receptor Encephalitis
  • Expanding the Phenotype of Autoimmune Associated Epilepsies
  • Natural Language Processing Analyses of Written Text Across Stages of Illness in Anti-NMDA Receptor Encephalitis
  • Neuronal Septin Autoimmunity: Differentiated Serological Profiles & Clinical Findings
  • Sleep Disorders in Autoimmune Encephalitis

Behavioral Neurology

  • Autopsy Correlations of Flortaucipir and Pittsburgh Compound B Pet in Frontotemporal Lobar Degeneration
  • Early Involvement of Amygdala in Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)
  • Eye Movements Abnormalities as Early Biomarker of Alzheimer’s Disease: An Ecological Approach
  • Lesion Network Mapping of Mania Symptoms Caused by Focal Brain Lesions
  • Selective Vulnerability in Frontotemporal Dementia
  • The Upper Motor Neurons with TDP-43 Pathology Display Distinct Cellular Defects

Cerebrovascular Disease & Interventional Neurology

  • Corneal Confocal Microscopy: Corneal Nerve Loss In Acute Stroke Patients With Poor Pial Collaterals
  • Direct to Angio Suite: The Good, the Bad, and the Evidence
  • Post-stroke Dysphagia: Implications & Innovative Therapeutic Approaches
  • Racial, Ethnic & Economic Disparities in Stroke Care: The Past & the Future

Clinical Logic

  • Presentations by S. Andrew Josephson, MD, Raymond Price, MD, Megan Richie, MD, and Martin A. Samuels, MD

Education

  • Authentic Workplace Assessment through the Use of Entrustable Professional Activities
  • Competency Based Education - Neurology Subspecialty Fellowship Perspective
  • Development of a Database Containing Detail Bedside Neurological Examination and Final Diagnosis
  • Improving the Comfortability of Neurology Residents in Providing Care for Spanish-Speaking Monolingual Patients during Neurologic Emergencies
  • Measuring Competence Across the Continuum: Beyond the Milestones – Continuing Professional Development
  • Simulation for Neurologic Emergencies and Acute Scenarios (SNES) Course: A 4-Year Evolutionary Experience of Utilizing Simulation for Incoming PGY-2 Neurology Residents to Prepare Them for Independent Calls

Global Neurology

  • "Doctor Myself”: Barriers to Effective Diagnosis and Treatment of Zambians with Meningitis
  • Asylum-Seekers and Refugees in the U.S.: A Humanitarian Crisis
  • Building Research Careers in Global Health: Perspectives from Ghana and the U.S.
  • Building Research Careers in Global Health: Perspectives from Ghana and the U.S.
  • Characterization of HIV-Associated Neurocognitive Impairment in Older Persons with HIV in Lima, Peru
  • Clinician Educators in Global Health: Developing Neurological Care and Training in Zambia
  • Clinician Educators in Global Health: Perspectives from Kenya and the U.S.
  • Global Health at Home: Underserved Populations in the U.S.
  • Global Prevalence of Tuberculosis in the Central Nervous System: A Systematic Review and Meta-Analysis

Health Services Research

  • Advances and Challenges of Patient-Reported Outcomes Data to Track and Improve Provider and Patient Experiences
  • Increasing Out-of-Pocket Costs for Privately-Insured Neurology Patients
  • Interdisciplinary Home Visits for People with Advanced Parkinson's Disease and Related Disorders
  • Social Factors Related to Home-Based Telerehabilitation after Stroke
  • Teleneurology: A Retrospective

Movement Disorders

  • Altered Capicua Expression Drives Regional Purkinje Neuron Vulnerability Through Ion Channel Gene Dysregulation in Spinocerebellar Ataxia Type 1
  • Genetics of PD
  • HIV Protease Inhibitors Activate the Integrated Stress Response and Correct Diverse Dystonia Phenotypes in Mouse Models
  • Update on Huntington Disease
  • Update on Inherited Ataxias
  • Variants in Saposin D Domain of Prosaposin Gene are Linked to Parkinson’s Disease

Neurocritical Care

  • #COVID19: Extraordinary Times call for Extraordinary Measures #InThisTogether
  • Global Collaboration on Neurological Impacts of COVID-19
  • Multi-objective Control of Learnt Covid-19 Model
  • Neurocritical Care in the Era of COVID-19

Neurogenetics

  • A Diagnostic Ceiling for Exome Sequencing in Cerebellar Ataxia and Related Neurological Disorders
  • ADNC-RS, a Clinical-Genetic Risk Score, Predicts Alzheimer's Pathology in Autopsy-Confirmed Parkinson's Disease and Dementia with Lewy Bodies
  • ALS: Lessons from 10,000 Genomes
  • Cell Based Functional Screens to Resolve Genetic Variants
  • New Developments in CMT Genetics

Neuromuscular Disease

  • Characterizing the Histological and Behavioral Phenotypes of a Humanized Knock-In Mouse Modeling a Deep Intronic Mutation in Collagen VI-Related Dystrophy
  • Congenital Myopathies: New Advances in Therapy Development
  • DNAJB6 Isoform Switching: Mechanistic Insights and Therapeutic Potential for Limb Girdle Muscular Dystrophy 1D
  • Immunologic Biomarkers in Autoimmune Neuromuscular Disease
  • Machine Learning Optimized Dynamic Meta-analysis to Assess and Predict the Multifactorial Nature of Amyotrophic Lateral Sclerosis
  • Neuromuscular Immune Related Adverse Events of Immune Checkpoint Inhibitor Therapies: Towards Risk Mitigation and Targeted Therapies

Traumatic Brain Injury

  • Imaging Consciousness: fMRI, Connectomics and the Ascending Arousal Network
  • Investigating the Role of the Claustrum in Consciousness Recovery Following Severe Brain Injury
  • Lack of Efficacy of Stem Cells in the Treatment of Chemosensory Dysfunction
  • Paroxysmal Sympathetic Hyperactivity Syndrome in Severe Traumatic Brain Injury: Patient Characteristics, Utilization of Sedation, Analgesia and Anesthetic Intravenous Infusion Medications and Patient Outcome
  • Restoration of Neuronal Function After Coma
  • Tapping the Brain of the Comatose with EEG: Impairment and Recovery of Consciousness in the Critical Care Setting
Activity summary
Available credit: 
  • 21.75 AMA PRA Category 1 Credit™
    The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Neurological Association designates this for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 21.75 Participation
Activity opens: 
10/03/2020
Activity expires: 
10/17/2021
Rating: 
0

Available Credit

  • 21.75 AMA PRA Category 1 Credit™
    The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Neurological Association designates this for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 21.75 Participation
Please login or register to take this activity.